SCHEMBL23130138

SCHEMBL23130138

CNS(=O)(=O)CCC(=O)N[C@H]1Cc2cccc(CO)c2OB1O

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ADRA2A P08913 1/20 0.33
▸ ADRA1A P35348 1/20 0.33
▸ MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17336985 0.86 ACLY (0.31) —
SCHEMBL17336987 0.86 ACLY (0.31) —
SCHEMBL19228048 0.85 — —
SCHEMBL23130222 0.84 MAPT (0.36) MAPT
SCHEMBL23837356 0.83 — —
SCHEMBL23129663 0.82 TSHR (0.33) MAPT
SCHEMBL17347664 0.82 TSHR (0.33) MAPT
SCHEMBL19662854 0.81 — —
SCHEMBL23837332 0.81 — —
SCHEMBL23129882 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3154989-B1 BETA-LACTAMASE INHIBITORS VENATORX PHARMACEUTICALS INC (US) 2021-03-24 — — EP disclosed
Send feedback